<div>
  <ul>
    <li>
      <p>
        Lucid Lane, a California-based mental health tech company for substance abuse and medication dependence, has raised USD 16 million in a Series A funding round led by Accel Partners, with participation from Battery Ventures, AME Cloud Ventures, Morado Ventures, and several strategic angel investors.&nbsp;
      </p>
    </li>
  </ul>
  <ul>
    <li>
      <p>
        The funds will be used to scale operations and&nbsp;hire additional staff to its sales, business development, and product development teams. Following the latest funding, Eric Wolford, venture partner at Accel will also join the company&rsquo;s board of directors.
      </p>
    </li>
  </ul>
  <ul>
    <li>
      <p>
        The company also announced product enhancements including a medication taper management service and AI-powered engine. The engine uses patient vitals to detect individuals who require help, connects them to an on-demand counselor, and also produces customized treatment plans.&nbsp;
      </p>
    </li>
  </ul>
  <ul>
    <li>
      <p>
        Founded in 2017, Lucid Lane connects individuals who are dependent on opioids, medication, and other substances with their dedicated therapists via the web and mobile app. The company also offers Medication Assisted Treatments for patients diagnosed with substance use disorders.&nbsp;
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://techcrunch.com/2021/08/05/accel-leads-lucid-lanes-16m-round-aimed-at-treating-people-with-medication-dependency/">
      Techcrunch
    </a>
  </p>
  <p>
    <a href="https://www.businesswire.com/news/home/20210805005741/en/Lucid-Lane-Raises-16-Million-Series-A-From-Accel-and-Battery-Ventures-to-Help-People-Living-with-Medication-Dependence">
      Business Wire
    </a>
  </p>
</div>


All Updates

Lucid Lane raises USD 16 million in Series A funding